Abstract
Cytotoxic effector systems mediated by cells and humoral factors have been discovered and appear to play an important role in the host defense mechanism against infection and newly arising neoplasia. Several cytotoxic effector cells have been characterized, all of which have in common the ability to interact with and destroy unwanted target cells. However, the underlying molecular mechanism by which the cytotoxic cell destroys the target is not yet completely resolved. Several potential mechanisms have been proposed for cell mediated cytotoxicity (CMC), such as the necessity of cell to cell contact resulting in membrane perturbation, transfer of cytotoxic materials from the effector to the target, co-factors present on target cells that facilitate lysis, pore formation, etc. It is possible that all of these mechanisms may participate in a particular cytolytic reaction and different mechanisms may operate with different cytotoxic effector cells.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
B. Bonavida, T. P. Bradley, J. Fan, J. Hiserodt, R. Effros, and H. Wexler. Molecular interactions in T cell-mediated cytotoxicity. Immunol. Rev. 72:119, (1983).
B. Bonavida, T. P. Bradley, and E. A. Grimm. The single cell assay in cell-mediated cytotoxicity. Immunol. Today 4:196, (1983).
S. Targan, E. Grimm, and B. Bonavida. A single cell marker or active NK cytotoxicity: Only a fraction of target binding lymphocytes on killer cells. J. Clin. Immunol. 4:165, (1980).
J. C. Roder, A. Rosen, E. M. Fenyo, and F. A. Troy. Target-effector interaction in the natural killer cell system: Isolation of target structures. Proc. Natl. Acad. Sci. USA 76:1405. (1979).
J. A. Werkmeister, S. A. Helfand, T. Haliotis, H. Pross, and J. C. Roder. Specificity of natural killer (NK) cells: Nature of target cell structures. In NK Cells and Other Natural Effector Cells, RB Herverman (ed.) New York, Academic Press (1982).
R. B. Herberman. NK cells and other Natural Effector Cells. New York, Academic Press, (1982).
T. P. Bradley, and B. Bonavida. Mechanism of cell-mediated cytotoxicity at the single cell level. IV. Natural killing and antibody dependent cellular cytotoxicity can be mediated by the same human effector cells as determined by the single cell conjugate assay. J. Immunol. 129:2260, (1982).
S. C. Wright, and B. Bonavida. Studies on the mechanism of natural killer (NK) cell-mediated cytotoxicity. IV. Interferon-induced inhibition of NK target cell susceptibility is due to a defect in their ability to stimulate release of natural killer cytotoxic factors (NKCF). J. Immunol. 130:2965, (1983).
J. Safrit, S. C. Wright, and B. Bonavida. Mechanism of defective NK activity following irradiation with ultraviolet light. (submitted for publication).
B. Bonavida, J. Kiatz, and M. Gottlieb. Mechanism of defective NK cell activity in acquired immune deficiency syndrome (AIDS). I. Defective trigger on NK cells for NKCF production by target cells and restoration by IL-2. J. Immunol. 137:1157, (1986).
M. L. Weitzen, and B. Bonavida. Mechanism of inhibition of human natural killer activity by ultraviolet radiation. J. Immunol. 133:3128, (1984).
S. C. Wright, and B. Bonavida. Studies on the mechanism of natural killer cytotoxicity. I. Release of cytotoxic factors specific for NK sensitive target cells (NKCF) selectively cytotoxic to NK-sensitive target cells. J. Immunol. 130:2960, (1982).
S. C. Wright, M. L. Weitzen, R. Kahle, G. A. Granger, and B. Bonavida. Studies on the mechanism of natural killer cytotoxicity. I. Coculture of human PBL with NK-sensitive or resistant cell lines stimulates release of natural killer cytotoxic factors (NKCF) selectively cytotoxic to NK-sensitive target cells. J. Immunol. 130:2479, (1983).
G. Trincheri, and D. Santoli. Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells: Enhancement of human natural killer cells activity by interferon and antagonistic inhibition of susceptibility of target cells to lysis. J. Exp. Med. 147:1314, (1978).
S. C. Graves, J. Bramhall, S. C. Wright, and B. Bonavida. Studies on the mechanism of natural killer cell-mediated cytotoxicity. IX. Induction of release of natural killer cell cytotoxic factors (NKCF) from human peripheral blood lymphocytes by a phorbol ester and ionophores suggest a role for protein kinase C activation. (submitted for publication).
G. Trinchieri, D. Santoli, R. R. Dee, and B. B. Knowles. Antiviral activity induced by culturing lymphocytes with tumor-derived versus transformed cells. Enhancement of human natural killer cell activity by interferon, and antagonistic inhibition of susceptibility of target cells to lysis. J. Exp. Med. 147:1314, (1978).
A. Silva, B. Bonavida, and S. Targan. Mode of action of interferon-mediated modulation of natural killer cytotoxic activity: recruitment of pre-NK cells and enhanced kinetics of lysis. J. Immunol. 125:479, (1980).
S. C. Wright, and B. Bonavida. Studies on the mechanism of natural killer (NK) cell-mediated cytotoxicity. III. Interferon-pretreatment of effector cell augments the lytic activity of natural killer cytotoxic factors (NKCF). J. Immunol. 130:2960, (1983).
R. H. Goldfarb, T. T. Timonen, and R. B. Herberman. The role of neutral serum proteases in the mechanism of tumor cell lysis by human natural killer cells. In NK Cells and Other Natural Effector Cells, RB Herberman (ed.) New York, Academic Press (1982) p 931.
D. Hudig, D. Redelman, and L. Minning. Evidence for proteases with specificity of cleavage at aromatic amino acids in human natural cell-mediated cytotoxicity. In NK Cells and Other Natural Effector Cells, RB Herberman (ed). New York, Academic Press (1982) p 923.
S. C. Wright, and B. Bonavida. Evidence for the involvement of proteolytic enzymes in the production of natural killer cytotoxic factors. In Natural Killer Activity and Its Regulation, T Hoshino et al. (eds.) Amsterdam, Excerpta Medica (1984) p 145.
S. C. Wright, and B. Bonavida. YAC-1 variant clones selected for resistance to natural killer cytotoxic factors are also resistant to natural killer cell-mediated cytotoxicity. Proc. Natl. Acad. Sci. USA 80:1688, (1983).
S. C. Wright, K. Kane, W. R. Clark, and B. Bonavida. Studies on the mechanism of natural killer cell-mediated cytotoxicity. VIII. Evidence for the involvement of target cell papain-sensitive binding sites for natural killer cytotoxic factors in NK CMC reactions. (submitted for publication).
S. C. Wright, and B. Bonavida. Studies on the mechanism of natural killer cell-mediated cytotoxicity. X. Evidence for the role of NKCF in the NK lytic mechanism: U-937 variants resistant to TNF- are still NK sensitive in CMC reactions whereas variants resistant to NKCF are NK resistant. (submitted).
S. C. Wrigth, J. C. Roder, J. Werkmeister, and B. Bonavida. Studies on the mechanism of natural killer (NK) cell-mediated cytotoxicity. VI. The NK resistant YAC-6–28 variant binds NK cells and stimulates release of natural killer cytotoxic factors (NKCF) but is not susceptible of lysis by NKCF. (submitted for publication).
R. C. Roozemond, P. Van der Geer, and B. Bonavida. Effect of altered membrane structure on NK cell mediated cytotoxicity II. Conversion of NK-resistant tumor cells into NK sensitive targets upon fusion with liposomes containing NK-sensitive membranes. J. Immunol. (In press).
R. C. Roozemond, D. C. Urli, S. C. Wright, S. C. Graves and S. C. Bonavida. Lysis of natural killer-resistant tumor cells by liposome-encapsulated natural killer cytotoxic factors (NKCF) as a proof that cell surface receptors for NKCF are not functionally involved in the actual killing process (submitted for publication).
S. C. Wright, S. M. Wilbur, and B. Bonavida. Studies on the mechanism of natural killer cell-mediated cytotoxicity. VI. Characterization of human, rat, and murine natural killer cytotoxic factors. Natl. Immun. Cell Growth Resul. 4:202, (1985).
G. A. Granger, S. L. Orr and R. S. Yamamoto. Lymphotoxins, macrophage cytotoxins, and tumor necrosis factors: An interrelated family of antitumor effector molecules. J. Clin. Immunol. 5:217, (1985)
M. L. Weitzen, R. S. Yamamoto, and G. A. Granger. Identification of human lymphocyte derived lymphotoxins with binding and cell lytic activity on NK-sensitive cell lines in vitro. Cell. Immunol. 77:30, (1983).
P. Gray, B. Aggarwal, C. Benton, T. Bringman, W. Henzel, J. Jarrett, D. Leung, B. Moffat, P. Ng, L. Sevedersky, M. Palladino, and G. Nedwin. Cloning and expression of the cDNA for human lymphotoxins: A lymphokine with tumor necrosis factor. Nature 312:721. (1984).
S. C. Wright, and BH. Bonavida. Studies on the mechanism of natural killer cell-mediated cytotoxicity. IX. Functional comparison of human natural killer cytotoxic factors with recombinant lymphotoxin and tumor necrosis factor. (submitted).
E. Carswell, L. Old, R. Kassel, S. Green, N. Fiore, and B. Williamson. An endotoxin-induced serum factor that causes necrosis of tumors. Proc. Natl. Acad. Sci. USA 72:3666. (1985).
D. Pennica, G. E. Nedwin, J. S. Hayflick, P. H. Seeburg, R. Deryuck, M. A. Palladino, W. J. Kohr, B. B. Aggarwal, and D. V. Goddel. Human tumor necrosis factor: precursor structure, expression and homology to lymphotoxin. Nature 312:724, (1984).
P. J. Millard, M. A. Henkart, C. W. Reynolds, and P. A. Henkart. Purification and properties of cytoplasmic granules from cytotoxic rat LGL tumors. J. Immunol. 123:3197, (1984).
E. R. Podak, and G. Dennert. Assembly of two types of tubules with putative cytolytic function in cloned natural killer cells. Nature 302:442, (1983).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Plenum Press, New York
About this chapter
Cite this chapter
Bonavida, B. (1987). Molecular Mechanism of Natural Killer Cell-Mediated Cytotoxicity. In: Gupta, S., Paul, W.E., Fauci, A.S. (eds) Mechanisms of Lymphocyte Activation and Immune Regulation. Advances in Experimental Medicine and Biology, vol 213. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5323-2_29
Download citation
DOI: https://doi.org/10.1007/978-1-4684-5323-2_29
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-5325-6
Online ISBN: 978-1-4684-5323-2
eBook Packages: Springer Book Archive